These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 27510588)

  • 21. Comorbidities remission after Roux-en-Y Gastric Bypass for morbid obesity is sustained in a long-term follow-up and correlates with weight regain.
    Laurino Neto RM; Herbella FA; Tauil RM; Silva FS; de Lima SE
    Obes Surg; 2012 Oct; 22(10):1580-5. PubMed ID: 22907795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short-Term Outcomes of Sleeve Gastrectomy plus Jejunojejunal Bypass: a Retrospective Comparative Study with Sleeve Gastrectomy and Roux-en-Y Gastric Bypass in Chinese Patients with BMI ≥ 35 kg/m
    Lin S; Guan W; Yang N; Zang Y; Liu R; Liang H
    Obes Surg; 2019 Apr; 29(4):1352-1359. PubMed ID: 30635811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased Metabolic Benefit for Obese, Elderly Patients Undergoing Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy.
    Gray KD; Moore MD; Bellorin O; Abelson JS; Dakin G; Zarnegar R; Pomp A; Afaneh C
    Obes Surg; 2018 Mar; 28(3):636-642. PubMed ID: 28852955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Duodenal switch provides superior resolution of metabolic comorbidities independent of weight loss in the super-obese (BMI > or = 50 kg/m2) compared with gastric bypass.
    Prachand VN; Ward M; Alverdy JC
    J Gastrointest Surg; 2010 Feb; 14(2):211-20. PubMed ID: 19937190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative fasting plasma C-peptide level may help to predict diabetes outcome after gastric bypass surgery.
    Aarts EO; Janssen J; Janssen IM; Berends FJ; Telting D; de Boer H
    Obes Surg; 2013 Jul; 23(7):867-73. PubMed ID: 23475775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Roux-en-Y gastric bypass with different pouch size in Chinese T2DM patients with BMI 30-35 kg/m2.
    Ren Y; Yang W; Yang J; Wang C
    Obes Surg; 2015 Mar; 25(3):457-63. PubMed ID: 25236397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conversion of standard Roux-en-Y gastric bypass to distal bypass for weight loss failure and metabolic syndrome: 3-year follow-up and evolution of technique to reduce nutritional complications.
    Ghiassi S; Higa K; Chang S; Ma P; Lloyd A; Boone K; DeMaria EJ
    Surg Obes Relat Dis; 2018 May; 14(5):554-561. PubMed ID: 29567059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of weight-loss surgery and diabetes status on serum ALT levels.
    Xourafas D; Ardestani A; Ashley SW; Tavakkoli A
    Obes Surg; 2012 Oct; 22(10):1540-7. PubMed ID: 22610995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of bariatric-metabolic surgery in the treatment of obese type 2 diabetes with body mass index <35 kg/m2: a literature review.
    Reis CE; Alvarez-Leite JI; Bressan J; Alfenas RC
    Diabetes Technol Ther; 2012 Apr; 14(4):365-72. PubMed ID: 22176155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship Between Vitamin D Deficiency and the Components of Metabolic Syndrome in Patients with Morbid Obesity, Before and 1 Year After Laparoscopic Roux-en-Y Gastric Bypass or Sleeve Gastrectomy.
    Obispo Entrenas A; Legupin Tubio D; Lucena Navarro F; Martin Carvajal F; Gandara Adan N; Redondo Bautista M; Abiles Osinaga J
    Obes Surg; 2017 May; 27(5):1222-1228. PubMed ID: 27864670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Standard vs Distal Roux-en-Y Gastric Bypass in Patients With Body Mass Index 50 to 60: A Double-blind, Randomized Clinical Trial.
    Risstad H; Svanevik M; Kristinsson JA; Hjelmesæth J; Aasheim ET; Hofsø D; Søvik TT; Karlsen TI; Fagerland MW; Sandbu R; Mala T
    JAMA Surg; 2016 Dec; 151(12):1146-1155. PubMed ID: 27626242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus.
    Schauer PR; Burguera B; Ikramuddin S; Cottam D; Gourash W; Hamad G; Eid GM; Mattar S; Ramanathan R; Barinas-Mitchel E; Rao RH; Kuller L; Kelley D
    Ann Surg; 2003 Oct; 238(4):467-84; discussion 84-5. PubMed ID: 14530719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative analysis of weight loss and resolution of comorbidities between laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass: A systematic review and meta-analysis based on 18 studies.
    Han Y; Jia Y; Wang H; Cao L; Zhao Y
    Int J Surg; 2020 Apr; 76():101-110. PubMed ID: 32151750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early results of Roux-en-Y gastric by-pass on regulation of diabetes type 2 in patients with BMI above and below 35 kg/m2.
    Proczko-Markuszewska M; Stefaniak T; Kaska Ł; Sledziński Z
    Pol Przegl Chir; 2011 Feb; 83(2):81-6. PubMed ID: 22166285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Equivalent weight loss with marked metabolic benefit observed in a matched cohort with and without type 2 diabetes 12 months following gastric bypass surgery.
    Yip K; Heinberg L; Giegerich V; Schauer PR; Kashyap SR
    Obes Surg; 2012 Nov; 22(11):1723-9. PubMed ID: 22895804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic Parameters, Weight Loss, and Comorbidities 4 Years After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy.
    Lager CJ; Esfandiari NH; Luo Y; Subauste AR; Kraftson AT; Brown MB; Varban OA; Meral R; Cassidy RB; Nay CK; Lockwood AL; Bellers D; Buda CM; Oral EA
    Obes Surg; 2018 Nov; 28(11):3415-3423. PubMed ID: 29909517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Laparoscopic Roux-en-Y gastric bypass surgery for morbid obesity. Experience at the Nacional de Ciencias Médicas y Nutrición Salvador Zubirán].
    Romero-Lbargüengoitia ME; Lerman-Garber I; Herrera-Hernández MF; Pablo-Pantoja J; Sierra-Salazar M; López-Rosales F; Zamora-Barrón M; Vargas-Martínez A; García-García E
    Rev Invest Clin; 2009; 61(3):186-93. PubMed ID: 19736806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term effects of laparoscopic sleeve gastrectomy versus roux-en-Y gastric bypass for the treatment of Chinese type 2 diabetes mellitus patients with body mass index 28-35 kg/m(2).
    Yang J; Wang C; Cao G; Yang W; Yu S; Zhai H; Pan Y
    BMC Surg; 2015 Jul; 15():88. PubMed ID: 26198306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term effects of laparoscopic Roux-en-Y gastric bypass on metabolic syndrome in patients with morbid obesity.
    Shah K; Johnny Nergard B; Stray Frazier K; Geir Leifsson B; Aghajani E; Gislason H
    Surg Obes Relat Dis; 2016; 12(8):1449-1456. PubMed ID: 27387692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term follow-up of the metabolic profiles in obese patients with type 2 diabetes mellitus after Roux-en-Y gastric bypass.
    Kim S; Richards WO
    Ann Surg; 2010 Jun; 251(6):1049-55. PubMed ID: 20485144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.